GB2596010B - Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents - Google Patents
Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents Download PDFInfo
- Publication number
- GB2596010B GB2596010B GB2113038.0A GB202113038A GB2596010B GB 2596010 B GB2596010 B GB 2596010B GB 202113038 A GB202113038 A GB 202113038A GB 2596010 B GB2596010 B GB 2596010B
- Authority
- GB
- United Kingdom
- Prior art keywords
- imipridone
- biomarker
- agents
- function
- drug response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962975088P | 2019-02-11 | 2019-02-11 | |
US201962811432P | 2019-02-27 | 2019-02-27 | |
US201962819204P | 2019-03-15 | 2019-03-15 | |
US201962825667P | 2019-03-28 | 2019-03-28 | |
US201962840254P | 2019-04-29 | 2019-04-29 | |
US201962871694P | 2019-07-08 | 2019-07-08 | |
US201962885055P | 2019-08-09 | 2019-08-09 | |
US201962901142P | 2019-09-16 | 2019-09-16 | |
US201962931043P | 2019-11-05 | 2019-11-05 | |
PCT/US2020/019944 WO2020176654A1 (en) | 2019-02-27 | 2020-02-26 | Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents |
Publications (3)
Publication Number | Publication Date |
---|---|
GB202113038D0 GB202113038D0 (en) | 2021-10-27 |
GB2596010A GB2596010A (en) | 2021-12-15 |
GB2596010B true GB2596010B (en) | 2023-03-01 |
Family
ID=78149387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2113038.0A Active GB2596010B (en) | 2019-02-11 | 2020-02-26 | Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2596010B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100113487A1 (en) * | 2007-04-20 | 2010-05-06 | Craig D Boyle | Pyrimidinone derivatives and methods of use thereof |
WO2015153468A1 (en) * | 2014-03-31 | 2015-10-08 | The Scripps Research Institute | Pharmacophore for trail induction |
WO2016184437A1 (en) * | 2015-05-15 | 2016-11-24 | 南京盖特医药技术有限公司 | Imidazo-pyrimidone compounds, and preparation method and application thereof |
WO2018031987A1 (en) * | 2016-08-12 | 2018-02-15 | Nanjing Gator Meditech Company, Ltd. | Protein kinase regulators |
WO2018031990A1 (en) * | 2016-08-12 | 2018-02-15 | Nanjing Gator Meditech Company, Ltd. | Protein kinase regulators |
-
2020
- 2020-02-26 GB GB2113038.0A patent/GB2596010B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100113487A1 (en) * | 2007-04-20 | 2010-05-06 | Craig D Boyle | Pyrimidinone derivatives and methods of use thereof |
WO2015153468A1 (en) * | 2014-03-31 | 2015-10-08 | The Scripps Research Institute | Pharmacophore for trail induction |
WO2016184437A1 (en) * | 2015-05-15 | 2016-11-24 | 南京盖特医药技术有限公司 | Imidazo-pyrimidone compounds, and preparation method and application thereof |
WO2018031987A1 (en) * | 2016-08-12 | 2018-02-15 | Nanjing Gator Meditech Company, Ltd. | Protein kinase regulators |
WO2018031990A1 (en) * | 2016-08-12 | 2018-02-15 | Nanjing Gator Meditech Company, Ltd. | Protein kinase regulators |
Non-Patent Citations (1)
Title |
---|
PUBCHEM, Substance Record for SID 90314507, Available Data: 22 February 2010 [retrived on 13 May 2020]. Retrieved from the Internet: <URL: https://pubchem.ncbi.nlm.nih.gov/substance/90314507/version/1>. entire document * |
Also Published As
Publication number | Publication date |
---|---|
GB2596010A (en) | 2021-12-15 |
GB202113038D0 (en) | 2021-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3930714A4 (en) | Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents | |
TWD176010S (en) | Watchcase | |
TWD176002S (en) | Watchcase | |
TWD177563S (en) | Watch | |
EP3268006A4 (en) | Pyrrolotriazine inhibitors of irak4 activity | |
TWD176009S (en) | Watchcase | |
TWD174047S (en) | Watch dial | |
EP3353292A4 (en) | Use of serine proteases for improving ethanol yield | |
TWD174041S (en) | Wristwatch | |
PL3230443T3 (en) | Detergents and cleaning agents comprising a combination of amylase and protease | |
TWD174040S (en) | Watch | |
TWD176798S (en) | Watchcase | |
ZA202100906B (en) | Diazabicyclooctanones as inhibitors of serine beta-lactamases | |
GB2596010B (en) | Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents | |
TWD169930S (en) | Wrist watch | |
TWD179028S (en) | Wristwatch | |
TWD175717S (en) | Watch | |
TWD194343S (en) | Billiard table | |
EP3844171A4 (en) | Enhancers of neurolysin activity | |
TWD176610S (en) | Watch | |
TWD173011S (en) | Wristwatch | |
PT3833665T (en) | Diazabicyclooctanones as inhibitors of serine beta-lactamases | |
TWD192899S (en) | Biscuits | |
EP3463374A4 (en) | A long acting pharmaceutical composition of protease inhibitor | |
TWD173934S (en) | sphygmomanometer |